New Hampshire 2023 Regular Session

New Hampshire Senate Bill SB239

Introduced
1/24/23  
Refer
1/24/23  
Report Pass
3/9/23  
Report Pass
3/22/23  
Engrossed
4/7/23  
Refer
4/7/23  

Caption

Relative to the use of harm reduction services to treat alcohol and other substance misuse.

Impact

The enactment of SB239 would significantly impact state laws related to substance use treatment and prevention, aligning them more closely with harm reduction principles. By incorporating recommendations from the governor's commission on alcohol and other drugs, the bill systematically integrates practices aimed at reducing harm associated with drug use. This includes the establishment of statewide access points for treatment services that would be funded at least in part through federal grants, ensuring ongoing resources for these vital public health initiatives.

Summary

Senate Bill 239, known as the Harm Reduction Services Act, aims to enhance the response to alcohol and substance misuse through the establishment of various statewide programs focused on harm reduction. The bill codifies the Doorways program, which serves as a point of entry for delivering substance use services, including screening, treatment referrals, and peer recovery support. It also expands the existing syringe services program to further support individuals affected by substance misuse and improve public health outcomes in New Hampshire.

Contention

Despite its supportive premise, SB239 has faced criticism due to potential challenges associated with federal funding variability and the execution of harm reduction strategies. Opponents are concerned that an overreliance on federal grants may leave the state vulnerable, particularly if these funds diminish in future years. Supporters argue that the expansion of treatment resources is crucial, while critics emphasize the need for adequate oversight and permanency in funding to sustain these essential programs over time.

Companion Bills

No companion bills found.

Similar Bills

CA SB1290

Substance abuse disorder treatment.

NJ A3974

Prohibits use of deceptive marketing practices by substance use disorder treatment providers.

NJ S3955

Prohibits use of deceptive marketing practices by substance use disorder treatment providers.

NJ A2972

Requires DHS to establish sobriety standards and drug testing requirements for substance use disorder treatment centers and to conduct both announced and unscheduled inspections.

CA AB541

Tobacco assessment.

CA AB2230

Tobacco assessment.

MN SF271

Substance abuse counselors license requirements modifications and treatment requirements modifications

MN HF2575

Continuing education requirements for licensed alcohol and drug counselors modified, religious objections to placements in substance use disorder treatment programs allowed, comprehensive assessment requirements modified, and courts or other placement authorities prohibited from compelling an individual to participate in religious elements of substance use disorder treatment.